Balancing the risks and benefits of proton pump inhibitors
- PMID: 21555747
- PMCID: PMC3090427
- DOI: 10.1370/afm.1269
Balancing the risks and benefits of proton pump inhibitors
Comment on
-
Use of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies.Ann Fam Med. 2011 May-Jun;9(3):257-67. doi: 10.1370/afm.1243. Ann Fam Med. 2011. PMID: 21555754 Free PMC article.
References
-
- Wolfe, MM, Sachs, G. Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome. Gastroenterology. 2000;118 (2 Suppl 1):S9–S31. - PubMed
-
- DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005;100(1):190–200. - PubMed
-
- Poynard T, Lemaire M, Agostini H. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer. Eur J Gastroenterol Hepatol. 1995;7(7):661–665. - PubMed
-
- Wallace JL. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology. 1997;112(3): 1000–1016. - PubMed
-
- Lanza FL, Chan FKL, Quigley EMM; Practice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol. 2009;104(3):728–738. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical